Type-2 Diabetes: Examination of cardiovascular Risk Profile of oral Semaglutide

被引：0
|
作者：
Lichert, Frank
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2019年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Type-2 Diabetes: Examination of cardiovascular Risk Profile of oral Semaglutide Comment
    Ritzel, Robert
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2019, 14 (06) : 436 - 437
  • [2] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Zweck, Elric
    Westenfeld, Ralf
    Szendroedi, Julia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2075 - 2076
  • [3] Will oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 489 - 492
  • [4] Cardiovascular Risk of Semaglutide in Patients With Type 2 Diabetes
    Marso
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (02) : 159 - 159
  • [5] A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
    Yanai, Hidekatsu
    Hakoshima, Mariko
    Adachi, Hiroki
    Katsuyama, Hisayuki
    [J]. CARDIOLOGY RESEARCH, 2022, 13 (05) : 303 - 308
  • [6] Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Husain, Mansoor
    Birkenfeld, Andreas L.
    Donsmark, Morten
    Dungan, Kathleen
    Eliaschewitz, Freddy G.
    Franco, Denise R.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Mosenzon, Ofri
    Pedersen, Sue D.
    Tack, Cees J.
    Thomsen, Mette
    Vilsboll, Tina
    Warren, Mark L.
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09): : 841 - 851
  • [7] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes reply
    Husain, Mansoor
    Donsmark, Morten
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2076 - 2077
  • [8] Oral semaglutide in type 2 diabetes
    Anderson, Sarah L.
    Beutel, Trevor R.
    Trujillo, Jennifer M.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (04)
  • [9] Cardiovascular risk management in type-2 diabetes: Is the patients' cardiovascular risk adequately considered in type-2 specialist diabetes care?
    Brenner, Sophie
    Daikeler, Richard
    Oberaigner, Willi
    Stummer, Harald
    [J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2021, 167 : 6 - 14
  • [10] Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care
    Morieri, Mario Luca
    Candido, Riccardo
    Frontoni, Simona
    Disoteo, Olga
    Solini, Anna
    Fadini, Gian Paolo
    [J]. DIABETES THERAPY, 2023, 14 (12) : 2159 - 2172
12345